Name: CAI Balance Sheet - Caris Life Sciences Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CAI - Caris Life Sciences, Inc.

USD | NASDAQ | Healthcare

CAI Balance Sheet - Caris Life Sciences Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022
Cash And Short Term Investments
Cash And Equivalents	796.3	64.0	-	-
Restricted Cash	1.5	1.5	-	-
Short Term Investments	2.3	2.2	-	-
Cash And Short Term Investments	798.6	66.2	-	-
Receivables
Accounts Receivable	112.1	88.2	-	-
Current Assets
Inventory	-	-	-	-
Prepaid Expenses	21.9	20.3	-	-
Other Current Assets	2.4	6.7	-	-
Non-Current Assets
Property, Plant & Equipment Gross	304.2	296.4	-	-
Accumulated Depreciation	241.0	228.6	-	-
Property,Plant & Equipment Net	63.2	67.8	-
Current Liabilities
Accounts Payable	39.2	27.8	-	-
Short Term Debt	0.2	60.1	-	-
Deferred Revenue Current	24.5	7.5	-	-
Non-Current Liabilities
Long Term Debt	378.8	319.4	-	-
Operating Lease Liabilities Non-Current	42.3	38.7	-	-
Deferred Revenue Non-Current	-	-	-
Common Equity
Common Stock	0.3	0.0	-	-
Additional Paid In Capital	3,141.7	0.0	-	-
Retained Earnings	(2,548.7)	(2,472.3)	-
Supplementary Data
Total Debt	379.0	379.5	-	-
Net debt	(419.6)	313.4	-	-
Working Capital	870.7	50.3	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q4 FY 22
Cash And Short Term Investments
Cash And Equivalents	819.9	-	753.2	718.9	31.2	64.0	-	-	-	-	-
Restricted Cash	-	-	1.5	1.5	-	1.5	-	-	-	-	-
Short Term Investments	2.3	2.3	2.3	2.2	-	2.2	-	-	-	-	-
Cash And Short Term Investments	822.2	-	755.5	721.2	31.2	66.2	-	-	-	-	-
Receivables
Accounts Receivable	90.5	112.1	26.7	50.9	-	88.2	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	23.9	21.9	21.2
Non-Current Assets
Property, Plant & Equipment Gross	328.4	304.2	304.4	303.4	-	296.4	-	-	-	-	-
Accumulated Depreciation	245.7
Current Liabilities
Accounts Payable	69.8	39.2	29.0	28.7	-	27.8	-	-	-	-	-
Short Term Debt	0.2	0.2	0.2
Non-Current Liabilities
Long Term Debt	381.4	378.8	376.3	373.6	-	319.4	-	-	-	-	-
Operating Lease Liabilities Non-Current	43.5	42.3
Common Equity
Common Stock	0.3	0.3	0.3	0.3	-	0.0	-	-	-	-	-
Additional Paid In Capital	3,158.5	3,141.7	3,124.9
Supplementary Data
Total Debt	381.6	379.0	376.5	373.7	-	379.5	-	-	-	-	-
Net debt	(440.6)	-	(379.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)